This is the authors' abstract. We don't add key points for this paper.
The MMTT is preferred for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Greenbaum et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: